Institution identification

PURI

https://redirect.ema.europa.eu/resource/3331119

Institution ID

3331119

Institution full name and acronym

Optimum Patient Care (OPC)

Institution countries

United Kingdom

Type of institution

Not-for-profit

Institution role

Data provider
Data holder

Institution website

ENCePP partner

No
Institution description
Optimum Patient Care is a not-for-profit, social enterprise, improving the diagnosis, treatment and management of chronic diseases within primary care.
Institution details
Experience with collecting data directly from individual patients or respondents:
Yes
Interest in carrying out research that is funded by pharmaceutical companies:
Yes

Contact

Studies conducted by the institution

Biologics in severe asthma: utilization patterns, causes for discontinuation and switches
Biomarker Relatability in the International Severe Asthma Registry (BRISAR)
CLinical oUtcomes before and after biologic treatMent by bIologic class, by iNdividuAl biologic, and by subgroups of baseliNe characTeristics (LUMINANT)
Defining and Characterizing Responders to Biologic Treatment (BEAM)
Demographic and Clinical Characteristics of Severe Asthma Patients Worldwide
Descriptive Study of the Incidence of Malignancy in Patients with Severe Asthma Overall and Among Those Receiving Benralizumab and Other Therapies, a Post Authorization Safety Study
Effectiveness across severe asthma biologic classes (Anti-IL-5 vs Anti IgE) in patients eligible for both (FIRE)
ImPact of comoRbidity In Severe asthMa patients (PRISM)
Impact of Initiating Biologics In Patients on Long-Term OCS Or Frequent Rescue Steroids (GLITTER)
International Severe Asthma Registry (ISAR)
Onset of asthma in severe asthma patients (PATH)
Patient characteristics, treatment patterns, clinical outcomes, and health care resource utilization in severe asthma subgroups: A retrospective analysis of the International Severe Asthma Registry (EVEREST)
PhEnotypic Characteristics, coMorBidities and response to thErapeutic inteRventions associated with non-type 2 asthma (EMBER)
The Characterization and Comparison of Eosinophilic and Non-eosinophilic Phenotypes of Severe Asthma
The Impact of Exacerbation Burden on Lung Function Trajectory in a Broad Asthma Population and Severe Asthma Population (Exacerbation and lung function trajectory)